On ECHEMI
Home > Drugs > Loxapine succinate Registered Holders
Loxapine succinate structure

Loxapine succinate structure

Loxapine succinate

Loxapine Succinate is a D2DR and D4DR inhibitor, serotonergic receptor antagonist and also a dibenzoxazepine anti-psychotic agent.IC50 value: Target: D2DR/D4DR; 5-HT receptorin vitro: In the presence of Loxapine, [3H]ketanserin binds to 5-HT2 receptor in Frontal cortex of brain in human and bovine with ki value of 6.2 nM and 6.6 nM, respectively. Loxapine has the rank order of potency for the various receptors appears to be as follows:5-HT2≥D4>>>D1>D2 in comparing competition experiments

Find 6 Related Holders

MEDICHEM SA
Spain Spain

API Registration Country

API Active
  • Country:

    Spain Spain
  • Address:

    FRUCTUOS GELABERT 6-8, BARCELONA, SANT JOAN DESPI
  • Email:

Zhejiang Hisun Pharmaceutical Co., Ltd.
China China

API Registration Country

API Active
  • Founded in:

    1998-02-11
  • Country:

    China China
  • Address:

    No. 46, Waisha Road, Jiaojiang District, Taizhou City, Zhejiang Province
  • Tax NO.:

    91330000704676287N
  • Registered Funds:

    1,207,873,716 yuan
  • Website:

  • Email:

CENTAUR PHARMACEUTICALS PRIVATE LTD
United States United States

API Registration Country

API Active
PROFARMACO SRL
United States United States

API Registration Country

API Inactive
AMERICAN CYANAMID CO.
Brazil Brazil

API Registration Country

API Inactive
  • Country:

    Brazil Brazil
  • Address:

    NAO INFORMADO, EXTERIOR - EX
  • Email:

MIKAH PHARMA LLC
United States United States

API Registration Country

API Inactive
Recommended Suppliers of Loxapine succinate
View 25 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.